Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Wade Insider Profile
4 Followers
Jeffrey Wade, President & COO at Lexicon Pharmaceuticals, holds 324.21K shares in Lexicon Pharmaceuticals (Ticker: LXRX).
Jeffrey Wade Lexicon Pharmaceuticals (LXRX)President & COO
Lexicon Pharmaceuticals (LXRX)
President & COO
Ranked #55,529 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-4.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & COO
Roles that Jeffrey Wade holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 14, 2023 - Sep 14, 2024
Return:+26.80%
The most profitable trade made by Jeffrey Wade
Jeffrey Wade's Trading History
List of latest transactions for each holding click on a transaction to see Jeffrey Wade's performance on stock
You May Also Like
Jeffrey Wade insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Wade?
The percentage of profitable transactions made by Jeffrey Wade is 33%.
What is the average return per transaction made by Jeffrey Wade?
The average return per transaction made by Jeffrey Wade is -4.40%.
What stocks does Jeffrey Wade hold?
Jeffrey Wade holds: LXRX stocks.
What was Jeffrey Wade’s latest transaction?
Jeffrey Wade latest transaction was an Uninformative Buy of $156.87K.
What was Jeffrey Wade's most profitable transaction?
Jeffrey Wade’s most profitable transaction was an Informative Buy of LXRX stock on September 14, 2023. The return on the trade was 26.80%.
What is Jeffrey Wade's role in Lexicon Pharmaceuticals?
Jeffrey Wade's role in Lexicon Pharmaceuticals is President & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.